Published in Obesity and Diabetes Week, April 19th, 2004
Serini, basing the company's outcome prediction on past experience, said that over a 3-year period, in aggregate, the approximately 10,000 patients enrolled in the XLHealth program will see a 50% reduction in amputations and other serious diabetes foot complications and a 50% decrease in repeat heart failure events.
Additionally, Serini said, "Though never measured before, the company plans to delay the progression...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week